rapid
technolog
develop
follow
human
genom
project
made
possibl
avail
person
genom
focu
shift
character
genom
make
person
diseas
associ
combin
avail
omic
technolog
next
big
push
obtain
person
genom
quantit
follow
omic
includ
transcriptom
proteom
metabolom
antibodyom
new
emerg
technolog
enabl
profil
thousand
molecular
compon
individu
furthermor
omic
profil
perform
longitudin
probe
tempor
pattern
associ
molecular
chang
associ
physiolog
health
diseas
state
data
necessit
develop
comput
methodolog
handl
descript
assess
data
also
construct
quantit
biolog
model
describ
avail
person
genom
develop
omic
technolog
brought
togeth
person
implement
novel
integr
approach
may
effect
provid
precis
person
medicin
focus
character
treatment
ultim
prevent
diseas
qb
advent
highthroughput
technolog
genom
scienc
experienc
great
leap
rapidli
expand
domain
beyond
character
short
genom
read
earli
day
sequenc
possibl
obtain
person
genom
consid
holi
grail
genom
methodolog
technolog
develop
valu
person
genom
analysi
evalu
variant
associ
diseas
becom
appar
even
spur
directli
consum
implement
develop
last
year
lead
ambiti
goal
longitudin
monitor
multipl
omic
compon
individu
character
molecular
chang
associ
diseas
onset
individu
unpreced
level
review
describ
technolog
methodolog
develop
person
genom
new
promis
multipl
omic
profil
includ
transcriptom
proteom
metabolom
autoantibodyom
forth
sampl
omic
analysi
workflow
shown
figur
discuss
framework
data
may
integr
view
toward
applic
person
precis
prevent
medicin
describ
implement
approach
technolog
develop
methodolog
allow
inroad
futur
quantit
person
medicin
plan
care
take
account
scientif
develop
need
implement
also
social
implic
coupl
ethic
legal
consider
complet
human
genom
project
hgp
announc
effect
public
first
complet
human
genom
sequenc
hgp
came
hefti
billion
cost
use
best
technolog
time
make
seemingli
prohibit
expect
person
genom
sequenc
achiev
shortli
thereaft
yet
immens
technolog
advanc
spur
motiv
nation
institut
health
nih
nation
human
genom
research
institut
nhgri
bring
genom
cost
led
unpreced
growth
technolog
methodolog
enabl
drop
sequenc
cost
http
www
genomegovsequencingcost
continu
rate
beyond
optimist
project
current
initi
human
genom
combin
multipl
individu
genom
data
develop
allow
determin
genom
individu
makeup
possibl
person
whole
genom
sequenc
wg
dwindl
sequenc
cost
promis
possibl
afford
near
futur
develop
encourag
effort
character
diseas
genom
level
toward
applic
allencompass
genom
medicin
molecular
level
initi
goal
character
popul
larg
studi
shift
individu
hgp
reli
technolog
use
sangerbas
capillari
sequenc
estim
product
base
pair
per
day
kbpday
nhgri
spur
progress
encourag
genom
program
http
lead
industri
develop
multipl
massiv
parallel
sequenc
platform
eg
base
pyrosequenc
life
technolog
solid
illumina
complet
genom
base
dna
nanobal
sequenc
helico
bioscienc
recent
singl
molecul
realtim
technolog
pacif
bioscienc
next
gener
sequenc
platform
supplement
term
thirdgener
sequenc
includ
nanopor
technolog
announc
earli
oxford
nanopor
technolog
technolog
develop
competit
result
drastic
continu
drop
sequenc
cost
process
time
exponenti
increas
number
read
produc
altern
sequenc
whole
genom
whole
exom
sequenc
we
technolog
aim
studi
exon
region
genom
associ
sever
mendelian
disord
offer
lower
cost
option
eg
illumina
agil
niblegen
platform
see
clark
et
al
comparison
latter
two
receiv
immens
attent
includ
exom
sequenc
project
esp
see
exom
variant
server
http
ev
gswashingtoneduev
support
nation
heart
lung
blood
institut
nhlbi
concurr
technolog
develop
understand
human
genom
grown
immens
sinc
public
refer
genom
aim
determin
precis
role
base
genom
identifi
genom
variant
figur
sever
collabor
largescal
effort
pursu
investig
intern
hapmap
consortium
tri
identifi
common
popul
variant
led
develop
public
databas
dbsnp
http
wwwncbinlmnihgovsnp
catalogu
singl
nucleotid
polymorph
snp
defin
occur
popul
differenti
singl
nucleotid
variant
snv
reveal
great
genom
variat
global
popul
popul
admix
ancestri
typic
technolog
involv
assign
read
refer
genom
determin
structur
underli
sequenc
includ
variat
figur
beyond
nucleotid
variat
genom
differ
investig
includ
small
insert
delet
indel
copi
number
variat
cnv
indic
vari
number
segment
longer
chromosom
segment
contribut
structur
variat
sv
sv
defin
segment
chromosom
larger
bp
figur
effort
base
microarray
methodolog
even
higherresolut
structur
variant
may
achiev
method
structur
variant
public
made
avail
databas
genom
structur
variat
dbvar
http
wwwncbinlmnihgovdbvar
furthermor
function
element
extens
catalogu
encyclopedia
dna
element
consortium
encod
http
product
project
fund
nhgri
encod
data
includ
regulatori
element
rna
protein
level
element
releas
project
receiv
widespread
attent
encod
project
aim
biochem
genom
character
thorough
map
transcrib
region
transcript
factor
bind
site
open
chromatin
signatur
chromatin
modif
dna
methyl
extens
data
still
need
annot
interpret
term
biolog
signific
mechan
connect
phenotyp
like
prove
invalu
interpret
person
genom
differ
though
initi
limit
number
complet
genom
sequenc
data
continu
updat
expand
inform
project
genom
project
discuss
qb
figur
genom
variant
variat
human
genom
person
genom
code
differ
publish
refer
genom
basic
exampl
variat
shown
singl
base
variant
eg
point
mutat
insert
delet
larger
scale
structur
variant
bp
eg
larg
insert
delet
invers
tandem
repeat
transloc
b
sampl
variant
analysi
workflow
genom
variant
analysi
exampl
sampl
prepar
sequenc
raw
file
pass
qualiti
control
eg
use
fastqc
http
wwwbioinformaticsbbsrcacukproject
fastqc
remov
pcr
artifact
use
tool
picard
http
picardsourceforgenet
read
map
genom
variant
assess
eg
map
sever
algorithm
includ
eland
ii
illumina
soap
maq
burrowswheel
align
bwa
novoalign
novocraft
technolog
http
wwwnovocraftcom
read
realign
perform
eg
use
genom
analysi
toolkit
gatk
hugeseq
call
variant
includ
implement
sequenc
align
map
format
tool
samtool
annot
use
annovar
sift
polyphen
determin
variant
effect
proteom
translat
furthermor
use
varieti
method
structur
variant
determin
exampl
pairedend
map
method
consid
pairedend
read
map
refer
assign
delet
insert
read
whose
map
span
longer
shorter
averag
span
invers
posit
rel
orient
end
read
read
depth
method
allow
possibl
identifi
proport
genom
copi
number
variat
approach
abyzov
et
al
read
depth
consid
imag
analyz
use
imag
process
techniqu
viz
meanshifttheori
program
pindel
breakseq
consid
splitread
analysi
determin
breakpoint
insert
delet
delli
rausch
et
al
take
account
pairedend
splitread
method
determin
structur
variant
mani
packag
analysi
avail
bioconductor
project
implement
freeli
avail
r
statist
analysi
platform
http
wwwrprojectorg
allow
us
better
view
great
variabl
individu
genom
snp
sv
vari
size
sv
kbp
much
variat
consid
rare
genomewid
associ
studi
gwa
tri
associ
common
variant
diseas
combin
readili
avail
extens
variant
inform
allel
variabl
linkag
disequilibrium
descript
correl
pattern
proxim
variant
nhgri
provid
public
avail
catalogu
publish
gwa
http
wwwgenomegov
gwastudi
earli
expect
find
common
trait
genom
featur
uniqu
diseas
proven
complic
genom
variabl
turn
higher
expect
addit
genet
variant
need
valid
use
wg
we
success
identif
somat
mutat
mendelian
disord
includ
neurolog
disord
cancer
character
use
we
includ
recent
singlecel
studi
genom
may
help
classifi
cancer
subtyp
possibl
treatment
research
center
wg
project
cancer
genom
atla
http
cancergenomenih
gov
intern
cancer
genom
consortium
http
wwwicgcorg
addit
cancer
specif
public
databas
alreadi
avail
includ
cancer
cell
line
encyclopedia
genom
character
carri
exampl
ovarian
cancer
melanoma
lymphocyt
leukemia
breast
cancer
acut
myeloid
leukemia
aml
one
goal
person
genom
interpret
evalu
diseas
risk
factor
base
individu
variant
allel
distribut
composit
inform
may
compar
similar
individu
known
diseas
associ
assess
whether
individu
show
increas
decreas
risk
compar
control
group
combin
know
snp
person
variant
found
effect
use
clinic
studi
recent
semin
studi
ashley
et
al
evalu
diseas
risk
patient
famili
histori
vascular
diseas
person
evalu
potenti
drug
respons
base
effect
variant
includ
drug
select
sensit
dosag
estim
eg
cardiovascular
drug
schizophrenia
relat
medic
exampl
pharmgkb
http
wwwpharmgkb
org
provid
curat
databas
possibl
genom
inform
explor
impact
genom
variat
drug
respons
relat
express
gene
associ
pathway
disord
futur
applic
includ
precis
drug
dosag
individu
avoid
trial
error
method
provid
effect
treatment
evalu
person
risk
base
genom
appear
directtoconsum
servic
compani
like
decodem
previous
navigen
offer
assess
individu
genotyp
offer
diseas
base
interpret
servic
base
mendelian
disord
evalu
includ
pharmacogenom
respons
mostli
base
snp
evalu
test
though
limit
scope
offer
interpret
attract
multipl
consum
present
thousand
genom
complet
sequenc
one
first
larg
scale
project
genom
project
made
data
public
avail
encourag
develop
streamlin
bioinformat
tool
analyz
variat
individu
genom
figur
project
aim
combin
data
individu
multipl
popul
coverag
anoth
grand
scale
effort
driven
georg
church
group
harvard
univers
person
genom
project
pgp
project
recruit
individu
share
medic
inform
togeth
genom
inform
onlin
http
wwwpersonalgenomesorg
volunt
share
full
dna
sequenc
rna
protein
profil
inform
addit
extens
phenotyp
inform
includ
medic
record
environment
consider
data
made
public
avail
plan
expand
individu
one
rather
uniqu
featur
pgp
project
differ
consent
particip
compar
tradit
studi
ownership
data
open
public
avail
without
restrict
initi
perspect
studi
open
followup
addit
investig
scope
participatori
volunt
project
interact
directli
research
address
inform
consent
particip
pass
basic
genet
literaci
exam
must
understand
project
scope
addit
provid
complet
medic
histori
immun
medic
histori
becom
part
public
avail
subject
inform
access
individu
data
project
either
privat
particip
research
complet
public
depend
particip
choic
avail
extens
patient
omic
inform
invalu
research
develop
robust
analysi
model
character
genom
diseas
pgp
project
public
open
structur
model
forefront
effort
though
genet
code
dna
almost
ident
besid
cellular
variat
differ
cell
differ
gene
express
correspond
kind
cell
development
stage
physiolog
state
collect
transcript
cell
eg
mrna
noncod
rna
small
rna
transcriptom
essenti
understand
cell
function
respons
diseas
consider
must
includ
start
end
site
gene
code
altern
splice
posttranscript
modif
initi
inroad
made
use
highdens
oligo
microarray
inhous
custom
made
microarray
highdens
array
resolut
bp
rel
inexpens
method
suffer
reli
prior
knowledg
genom
face
technic
issu
background
satur
effect
hybrid
interact
probe
set
short
oligo
microarray
lead
spuriou
correl
develop
rna
sequenc
rnaseq
brought
higher
coverag
better
precis
quantit
higher
resolut
sensit
bring
rnaseq
technolog
transcriptom
par
genom
sequenc
rnaseq
consid
read
correspond
million
transcriptom
fragment
map
refer
genom
provid
inform
transcript
may
exist
genom
annot
allow
search
novel
transcript
even
identif
snp
variant
show
remark
reproduc
figur
transcriptom
profil
includ
look
cancer
includ
breast
cancer
gastrointestin
tumor
prostat
cancer
gene
express
expect
correl
protein
level
cell
thought
method
rnaseq
would
enough
ascertain
proteom
express
correspond
gene
express
protein
expect
closer
phenotyp
particip
everi
aspect
cellular
biolog
express
level
difficult
quantit
partli
translat
control
cell
possibl
degrad
sampl
issu
develop
electrospray
ioniz
brought
mass
spectrometri
ms
field
proteom
possibl
identif
thousand
molecul
base
mass
enabl
catalogu
protein
also
queri
posttransl
modif
techniqu
matur
liquid
chromatographi
tandem
mass
spectrometri
lcmsm
becom
standard
novel
instrument
eg
velo
famili
thermo
scientif
quadrupol
timeofflight
mass
spectromet
qtof
agil
allow
unpreced
precis
enabl
develop
method
qb
figur
rnaseq
analysi
rnaseq
analysi
short
read
assembl
map
refer
genom
tool
illumina
eland
maq
bwa
bowti
soap
other
recent
protocol
trapnel
et
al
describ
detail
use
dedic
rnaseq
program
tuxedo
suit
tophat
cufflink
r
implement
call
cummerbund
bioconductor
packag
altern
run
directli
use
genepattern
also
includ
possibl
reconstruct
scriptur
program
deseq
anoth
packag
bioconductor
also
help
test
differenti
express
numer
analys
avail
public
discuss
onlin
forum
http
seqanswerscom
discuss
mani
exampl
aspect
map
process
identifi
thousand
protein
day
quantit
protein
level
figur
one
set
method
use
stabl
isotop
label
amino
acid
cell
cultur
silac
label
cell
light
heavi
isotop
amino
acid
provid
doubl
spectral
peak
ms
identif
quantit
method
supplement
spikeinsup
silac
use
measur
biopsi
tumor
proteom
anoth
possibl
use
isobar
tag
rel
absolut
quantit
itraq
tandem
mass
tag
tmt
label
method
includ
spike
peptid
absolut
quantit
final
possibl
employ
labelfre
method
quantit
reli
tag
includ
integr
signal
method
ms
spectral
count
comparison
whole
transcriptom
profil
number
protein
identifi
proteom
profil
tend
less
comparison
particularli
sinc
low
peptid
level
amplifi
cf
polymeras
chain
reaction
method
sequenc
method
addit
current
bottomup
shotgun
proteom
methodolog
use
digest
endopeptidas
trypsin
obtain
peptid
small
enough
mass
identifi
msm
result
mani
fragment
identifi
ms
may
possibl
allevi
top
approach
employ
digest
step
howev
proteom
provid
insight
miss
transcriptom
analysi
especi
given
low
correl
protein
transcriptom
differenti
gene
express
multipl
proteom
quantit
profil
includ
character
ovarian
cancer
integr
approach
combin
transcriptom
proteom
inform
human
cancer
cell
line
nagaraj
et
al
integr
gastric
cancer
character
effect
posttransl
modif
look
biomark
cancer
addit
develop
proteom
ms
encourag
studi
small
molecul
behavior
small
molecul
cell
though
difficult
track
provid
insight
mani
common
disord
set
cellular
small
molecul
collect
call
metabolom
metabol
process
vital
biolog
pathway
system
analysi
molecular
cell
complex
might
lead
biomark
discoveri
possibl
diseas
risk
assess
diagnosi
treatment
similar
proteom
metabolom
employ
mass
spectrometri
identifi
compound
quantit
proteom
use
mass
spectrometri
typic
approach
employ
trypsin
digest
coupl
tag
methodsnon
labelfre
method
includ
use
isotop
label
silac
isobar
tag
itraq
tmt
one
typic
bottomupapproach
setup
use
combin
high
affin
liquid
chromatographi
coupl
two
round
mass
spectrometri
lcmsm
fraction
peptid
identif
obtain
mass
spectra
raw
file
may
analyz
use
vendor
softwar
convert
open
format
mzxml
mzdata
current
standard
mzml
eg
use
msconvert
mass
spectra
map
known
protein
use
protein
librari
less
frequent
de
novo
assembl
use
array
program
eg
x
tandem
sequest
mascot
open
mass
spectrometri
search
algorithm
omssa
proteom
discover
thermo
scientif
masshunt
workstat
agil
qualiti
control
includ
estim
fals
discoveri
rate
fdr
often
use
revers
databas
search
quantit
carri
estim
rel
level
protein
differ
sampl
employ
standard
normal
averag
sampl
ratio
unit
mean
final
annot
made
use
databas
uniprot
ncbi
analysi
perform
use
suit
program
peak
transproteom
pipelin
tpp
multipl
tool
proteowizard
openm
vendor
complet
solut
proteom
discover
masshunt
workstat
mention
multipl
program
mass
spectrometri
avail
eg
see
http
wwwmsutilsorg
catalogu
way
thousand
metabolit
identifi
structur
mass
occasion
associ
biolog
process
identif
compound
base
msm
applic
use
known
compound
spectra
via
use
standard
mass
spectra
compar
profil
metabol
compon
individu
basi
provid
insight
pharmacogenom
person
medic
addit
potenti
biomark
exampl
cholesterol
level
coronari
arteri
metabolom
cancer
extens
studi
type
diabet
investig
vivo
interact
protein
evalu
genom
transcriptom
metabolom
receiv
widespread
attent
current
offer
quantit
data
provid
robust
comprehens
omic
technolog
term
experiment
well
comput
methodolog
howev
multipl
omic
avail
number
increas
notabl
technolog
mention
autoantibodyom
addit
profil
protein
directli
reactiv
protein
autoantibodi
may
profil
larg
scale
spot
protein
array
implement
studi
exampl
effect
cancer
immun
respons
recent
diabet
anoth
approach
nucleic
acid
programm
protein
array
nappa
construct
spot
plasmid
dna
effect
express
code
protein
array
use
immunoprofil
furthermor
function
peptid
array
also
construct
complementari
technolog
beadbas
immunoassay
also
activ
develop
luminex
xmap
assay
microbiom
omic
profil
could
also
includ
map
person
microbiom
complet
set
microb
individu
eg
found
mainli
skin
gut
conjunctiva
saliva
mucosa
use
possibl
combin
omic
approach
look
genet
makeup
metabol
compon
human
microbiota
http
wwwhumanmicrobiomeorg
associ
obes
diabet
also
suspect
play
activ
role
develop
immun
dynam
monitor
microbiomerel
chang
help
identifi
specif
microbiota
involv
diseas
respons
elucid
microbiomehost
interact
individu
variabl
compon
impact
development
metabol
process
methylom
addit
genom
epigenom
inform
probe
methylom
ie
identifi
genom
site
cytosin
methyl
might
provid
inform
differenti
regul
gene
express
methyl
analysi
data
interpret
challeng
method
improv
data
becom
avail
methylom
analysi
carri
blood
compon
stem
cell
ovarian
cancer
might
prove
invalu
assess
epigenom
effect
individu
develop
metabolom
analysi
chromatographi
column
use
purif
prepar
sampl
coupl
mass
spectrometri
ga
chromatographi
gc
liquid
chromatographi
lc
ms
standard
specif
compound
may
also
use
parallel
posit
identif
raw
file
may
analyz
use
vendor
softwar
convert
open
format
mzxml
mzdata
current
standard
mzml
eg
use
msconvert
spectral
data
may
align
retent
time
mass
intens
calibr
eg
use
xcm
siev
thermo
scientif
matlab
toolbox
mathwork
masshunterprofil
agil
mzmine
qualiti
control
statist
analysi
mass
interest
annot
use
databas
eg
metlin
kegg
metacyc
reactom
health
develop
mani
differ
omic
technolog
outlin
given
us
tremend
insight
human
genom
associ
diseas
especi
rise
person
genom
nhgri
recogn
import
develop
direct
necessari
enhanc
health
care
outlin
vision
futur
person
medicin
encompass
five
domain
develop
includ
understand
structur
genom
biolog
improv
understand
biolog
diseas
advanc
medicin
improv
effect
healthcar
aim
set
shift
toward
person
medicin
within
two
decad
avail
technolog
constant
decreas
cost
made
pilot
investig
person
medicin
current
possibl
genet
variat
proven
adequ
understand
group
differ
disord
truli
person
implement
need
consid
individu
clinician
alreadi
consid
molecular
marker
evalu
patient
particularli
cancer
typic
clinic
diagnosi
involv
observ
symptom
tradit
confirm
util
small
set
molecular
marker
diseas
share
common
set
symptom
rare
diagnosi
often
complic
prolong
especi
heterogen
disord
need
addit
inform
enabl
classif
subsequ
specif
treatment
genet
environment
factor
creat
addit
variabl
diseas
sever
progress
treatment
respons
thu
tradit
assay
togeth
aforement
current
omic
technolog
allow
monitor
thousand
molecular
compon
facilit
acceler
differenti
diagnost
subclassif
util
complet
set
diseas
marker
person
approach
result
better
target
diseas
introduc
higher
precis
measur
larger
set
molecular
compon
ideal
implement
earli
age
assess
diseas
risk
prevent
rather
retrospect
treatment
focu
person
approach
natur
n
studi
help
elimin
variat
individu
treat
group
still
requir
verif
establish
baselin
comparison
profil
healthi
physiolog
state
longitudin
approach
may
provid
basi
multipl
time
point
similar
physiolog
state
makeup
sampl
multipl
omic
suppli
multipl
support
dataset
time
point
complementari
technolog
provid
addit
support
inform
baselin
establish
introduc
concept
complet
omic
monitor
individu
time
make
person
medicin
dynam
proposit
dynam
chang
molecular
compon
may
associ
individu
chang
physiolog
state
map
onto
pathway
identifi
onset
progress
diseas
includ
possibl
prevent
measur
suggest
implement
term
integr
person
omic
profil
ipop
follow
studi
discuss
integr
omic
compon
discuss
longitudin
approach
three
essenti
step
figur
risk
estim
discuss
person
common
genom
variant
determin
individu
genom
associ
diseas
pharmacogenom
evalu
determin
possibl
drug
respons
earli
age
whole
genom
sequenc
possibl
birth
provid
list
possibl
increas
risk
disord
lead
take
prevent
measur
may
done
combin
complet
medic
famili
histori
exampl
implement
pgp
project
conjunct
classic
clinic
risk
factor
profil
ii
dynam
profil
multipl
omic
start
healthi
steadi
state
baselin
monitor
chang
molecular
compon
multipl
time
point
drastic
gradual
chang
physiolog
state
might
assess
dynam
onset
diseas
profil
possibl
prevent
profil
may
done
blood
compon
easili
obtain
current
clinic
individu
blood
compon
excel
reflector
gener
physiolog
state
individu
blood
circul
receiv
input
multipl
tissu
throughout
bodi
compon
may
process
track
multipl
omic
transcriptom
proteom
metabolom
autoantibodyom
etc
mention
offer
complementari
inform
especi
given
modest
correl
observ
transcriptom
proteom
compon
recent
studi
profil
tumor
chang
time
also
employ
integr
approach
genom
transcriptom
compon
implement
monitor
healthi
individu
allow
monitor
diseas
onset
physiolog
chang
variou
healthi
diseas
recoveri
state
follow
thousand
molecular
compon
level
respons
correspond
physiolog
state
iii
data
integr
biolog
impact
assess
multipl
omic
data
analyz
individu
character
tempor
respons
profil
may
done
use
standard
statist
timeseri
analysi
extens
use
quantit
disciplin
physic
econom
financ
discuss
barjoseph
et
al
dynam
signatur
signal
molecular
compon
studi
autocorrel
period
spikey
behavior
correqb
figur
ipop
person
medicin
framework
describ
text
employ
multiom
analys
see
figur
may
implement
individu
step
risk
estim
diseas
carri
use
whole
genom
sequenc
perform
variant
analysi
coupl
medic
histori
environment
consider
pharmacogenom
evalu
step
ii
dynam
profil
multipl
omic
use
array
technolog
follow
multipl
omic
longitudin
subject
progress
differ
physiolog
state
includ
healthi
diseas
recoveri
state
thu
thousand
molecular
compon
collect
time
iii
data
integr
biolog
impact
assess
use
tempor
pattern
obtain
match
omic
inform
correl
classifi
respons
compar
pathway
databas
visual
compon
eg
current
pathway
tool
includ
david
kegg
reactom
ingenu
pathway
analysi
ipa
network
visual
use
cytoscap
variou
r
packag
bioconductor
matlab
mathwork
sever
other
futur
ipop
implement
may
gather
curat
databas
ipopdiseas
associ
may
help
categor
omic
dynam
respons
catalogu
physiolog
state
diseas
onset
potenti
diagnost
capabl
spond
causal
chang
abnorm
physiolog
state
condit
result
onset
diseas
infect
environment
effect
differ
class
tempor
respons
check
biolog
pathway
gene
ontolog
enrich
correspond
diseas
associ
comparison
databas
longitudin
profil
coupl
complet
electron
record
omic
medic
histori
databas
necessari
power
resourc
toward
realiz
person
medicin
base
omic
data
profil
show
feasibl
practic
applic
ipop
profil
healthi
individu
period
initi
month
initi
time
seri
cover
healthi
state
two
viral
state
includ
human
rhinoviru
hrv
infect
initi
studi
respiratori
syncyti
viru
rsv
infect
day
later
ipop
use
blood
sampl
extract
omic
compon
peripher
blood
mononuclear
cell
pbmc
serum
analyz
obtain
complet
dna
rna
protein
metabolit
autoantibodi
profil
initi
complet
medic
exam
perform
standard
clinic
test
timepoint
profil
began
first
step
wg
two
platform
carri
complet
genom
illumina
coverag
respect
we
three
platform
nimblegen
illumina
agil
help
identifi
larg
number
variant
snp
indel
sv
use
multipl
platform
allow
us
determin
highconfid
novel
variant
use
hugeseq
evalu
genet
diseas
risk
base
variant
carri
look
known
diseas
associ
use
dbsnp
onlin
mendelian
inherit
man
omim
http
omimorg
databas
use
riskogram
algorithm
integr
inform
multipl
allel
assess
risk
similarli
match
data
cohort
reveal
significantli
increas
risk
variou
disord
includ
open
angl
glaucoma
dyslipidemia
coronari
arteri
diseas
basal
cell
carcinoma
type
diabet
age
relat
macular
degener
psoriasi
encourag
subject
follow
disord
also
start
monitor
glucos
glycat
hemoglobin
level
surprisingli
increas
beyond
normal
level
follow
rsv
infect
subject
diagnos
physician
day
studi
relat
pharmacogenom
consider
reveal
possibl
favor
glucos
lower
respons
diabet
drug
rosiglitazon
metformin
treatment
becom
necessari
furthermor
autoantibodyom
profil
subject
invitrogen
protoarray
profil
protein
reactiv
immunoglobulin
g
igg
reveal
increas
reactiv
multipl
protein
includ
relat
insulin
receptor
btk
aspa
previous
report
show
high
reactiv
winer
et
al
insulin
resist
patient
subject
initi
still
maintain
strict
dietari
exercis
regiment
supplement
low
dose
acetylsalicyl
acid
help
control
glucos
level
consider
time
period
month
return
normal
level
addit
rang
omic
profil
time
differ
timepoint
span
studi
includ
high
coverag
transcriptom
rnaseq
pbmc
billion
read
map
isoform
correspond
gene
proteom
ms
pbmc
identifi
total
protein
consist
across
timepoint
metabolom
ms
serum
profil
metabolit
period
hrv
rsv
infect
respect
identifi
base
mass
retent
time
alon
dynam
transcriptom
proteom
metabolom
profil
analyz
novel
integr
framework
base
spectral
analysi
time
seri
allow
identif
tempor
pattern
combin
data
correspond
biolog
process
vari
physiolog
state
chang
includ
onset
seen
multipl
omic
compon
common
signatur
hrv
rsv
infect
sever
gene
associ
pathway
known
multipl
gene
show
similar
pattern
report
merit
investig
ipop
studi
discuss
reveal
complex
characterist
person
genom
transcriptom
proteom
metabolom
show
feasibl
person
longitudin
profil
provid
action
health
inform
multipl
omic
data
integr
still
present
formid
challeng
merit
develop
omic
technolog
produc
differ
kind
data
includ
multipl
format
eg
data
file
rang
simpl
text
extens
markup
eg
xml
vendor
closedsourc
format
addit
omic
set
requir
qualiti
control
analysi
confound
differ
error
nois
level
associ
differ
technolog
data
set
also
present
differ
signal
nois
distribut
make
uniform
normal
approach
across
omic
challeng
especi
consid
multimod
dynam
data
furthermor
amount
inform
per
omic
set
vari
eg
protein
transcript
isoform
metabolit
autoantibodyprotein
reactiv
forth
henc
genecentr
approach
integr
data
correspond
associ
interact
gene
alway
work
differ
compon
may
match
integr
inform
per
compon
made
difficult
multipl
exist
gene
protein
annot
often
result
manytomani
map
geneprotein
integr
correspondingli
lack
metaboliteproteingen
annot
associ
final
consid
dynam
dataset
also
result
multipl
instanc
time
point
might
miss
data
molecular
compon
especi
evid
mass
spectrometri
shotgun
proteom
protein
identifi
differ
peptid
complic
omic
data
integr
necessit
individu
omic
data
set
analyz
independ
normal
integr
inform
new
integr
methodolog
account
differ
normal
miss
data
also
integr
genebas
rather
incorpor
timeseri
analys
exampl
carri
ipop
studi
classif
chang
tempor
respons
possibl
interact
data
lead
interpret
compon
base
share
similar
dynam
avoid
issu
insuffici
annot
miss
inform
interpret
lend
clinic
set
dynam
chang
associ
vari
person
physiolog
state
may
adopt
medic
commun
facilit
wide
adopt
method
person
medicin
integr
data
analysi
requir
optim
current
comput
tool
rapidli
effici
handl
well
visual
multipl
omic
data
first
step
amount
comput
time
differ
analys
must
reduc
day
case
map
sequenc
data
quantit
proteom
current
omic
analys
present
hour
less
immedi
relev
activ
medic
examin
secondli
better
visual
omic
data
though
difficult
also
necessari
multidimension
inform
difficult
collat
present
interpret
mani
effort
address
eg
circo
plot
allow
multipl
sequenc
inform
display
togeth
wide
adopt
incorpor
inform
clinic
data
phenotyp
present
new
challeng
requir
browser
combin
tempor
inform
multidimension
omic
set
believ
network
analysi
present
excel
visual
integr
possibl
allow
combin
multipl
level
network
dynam
chang
includ
cellular
inform
compon
correspond
diseas
tempor
progress
well
medic
assay
data
modular
approach
comput
analys
visual
omic
data
integr
also
reveal
known
need
manag
larg
amount
data
term
process
power
well
storag
capac
maintain
easi
access
especi
practic
clinicianwith
recent
advent
cloud
comput
provid
one
possibl
solut
final
combin
omic
data
medic
record
present
anoth
challeng
privaci
ethic
issu
must
consid
improv
standard
approach
help
make
analysi
avail
clinic
set
increasingli
larger
set
patient
encourag
earli
adapt
integr
approach
scientif
commun
toward
person
medicin
applic
technolog
improv
expect
see
advanc
omic
implement
discuss
term
sequenc
continu
improv
depth
read
length
allow
unambigu
precis
sequenc
map
addit
queri
lower
gene
express
coupl
higher
accuraci
variant
call
sequenc
time
becom
faster
eg
whole
genom
sequenc
hour
depend
platform
deep
coverag
hardwar
compact
eventu
technolog
avail
clinic
enabl
incorpor
genom
transcriptom
microbiom
autoantibodyom
profil
part
regular
medic
examin
correspondingli
mass
spectrometri
improv
includ
tabletop
hardwar
avail
improv
mass
accuraci
higher
sensit
allow
increas
number
protein
identifi
better
quantit
alreadi
implement
clinic
set
ms
improv
combin
better
metabolit
catalogu
also
improv
identif
small
molecul
protocol
methodolog
advanc
allow
use
smaller
volum
patient
sampl
need
ipop
decreas
ml
drop
blood
make
feasibl
probe
omic
regular
basi
patient
even
provid
home
kit
send
selfcollect
sampl
akin
alreadi
implement
degre
compani
eg
collect
saliva
sampl
phenotyp
technolog
methodolog
advanc
allow
effect
ipop
implement
multipl
patient
still
take
time
evalu
constitut
action
inform
compon
inform
relev
compon
identifi
monitor
technolog
develop
help
possibl
clinic
implement
certainli
allevi
multipl
ipop
studi
provid
necessari
aggreg
inform
howev
clinic
psycholog
concern
need
address
possibl
impact
patient
health
paramount
import
medic
process
patient
activ
particip
activ
particip
requir
train
public
health
profession
understand
genom
inform
omic
knowledg
impact
health
famili
genet
counsel
necess
number
train
genet
counselor
steadili
increas
inform
consent
necessari
requir
understand
basic
genom
term
appar
nonexpert
facilit
probabl
school
curriculum
adjust
need
enabl
earli
educ
public
emerg
quantit
person
omic
includ
genom
transcriptom
proteom
metabolom
omic
allow
us
combin
yield
person
action
health
care
inform
research
forefront
medic
scienc
may
help
character
disord
implement
precis
person
medicin
aim
toward
prevent
rather
treatment
care
forward
plan
coupl
continu
interest
particip
public
govern
agenc
research
assur
develop
person
omic
proceed
beyond
possibl
hurtl
novel
approach
centuri
health
care
implement
